Processa Pharmaceuticals to Present at Access to Giving Virtual Conference on July 14, 2021 at 10:30 a.m. ET

Rhea-AI Summary

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) will present at the Access to Giving Virtual Conference on July 14, 2021, at 10:30 a.m. ET. The presentation will be led by CEO Dr. David Young. The conference targets a range of companies and facilitates one-on-one meetings with qualified investors, who will donate to participate. Processa focuses on developing treatments for unmet medical needs, supported by a team with extensive FDA approval experience. For registration, visit here.

HANOVER, MD, July 06, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that the company will present at Access to Giving Virtual Conference. The presentation will be given by Processa’s Chief Executive Officer, Dr. David Young.

Registration Details
Date: Wednesday, July 14, 2021
Time: 10:30 a.m. ET
Link: https://access-to-giving.events.issuerdirect.com/signup

To learn more about the event or to schedule a one-on-one meeting with Processa management, please visit https://www.accesstogiving.com/ or email james@haydenir.com.

About Access to Giving Virtual Conference

Access to Giving is a first-of-its-kind virtual investor conference where companies from microcap all the way up to megacap will have the opportunity to present their story and conduct 1x1 meetings with qualified investors, for charity. Investors will make donations to purchase a block of meetings to meet with companies.

About Processa Pharmaceuticals, Inc.

The mission of Processa has been to develop products where existing clinical evidence of efficacy already exists in unmet medical need conditions, medical conditions where patients need treatment options that will improve survival and/or quality of life. The Company has assembled a proven regulatory science development team, management team, and Board of Directors. The Processa development team has been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and 100 FDA meetings. For more information, please visit http://www.processapharma.com.

For More Information:
Michael Floyd
mfloyd@processapharma.com
(301) 651-4256

James Carbonara
Hayden IR
(646) 755-7412
james@haydenir.com

FAQ

When is Processa Pharmaceuticals presenting at the Access to Giving Virtual Conference?

Processa Pharmaceuticals will present on July 14, 2021, at 10:30 a.m. ET.

Who is presenting for Processa Pharmaceuticals at the conference?

CEO Dr. David Young will present on behalf of Processa Pharmaceuticals.

How can I register for the Access to Giving Virtual Conference?

You can register for the conference by visiting this link.

What is the purpose of the Access to Giving Virtual Conference?

The conference allows companies to present their stories and conduct one-on-one meetings with investors for charity.

What is Processa Pharmaceuticals' focus in drug development?

Processa Pharmaceuticals aims to develop products for unmet medical needs, enhancing survival and quality of life.